Abbott Laboratories (ABT) vs Pfizer Inc. (PFE)
PFE leads on 11 of 16 compared metrics.
A side-by-side comparison of Abbott Laboratories and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABT vs PFE
growth of $100 · last 30yABT +804.4%PFE +128.5%ABT compounded faster
ABT PFE
ABT vs PFE: by the numbers
- •ABT is the larger company ($153.59B vs $149.38B market cap).
- •PFE trades at the lower earnings multiple (20.01 vs 24.56 P/E).
- •ABT converts more revenue to profit (13.91% vs 11.83% net margin).
- •PFE grew revenue faster over the past five years (8.22% vs 3.87% CAGR).
- •PFE pays the higher dividend yield (6.56% vs 2.77%).
Which is better, ABT or PFE?
Metric tally: ABT 5 · PFE 11It depends on what you're optimizing for:
ValuePFE(lower P/E)
GrowthPFE(faster 5Y revenue CAGR)
IncomePFE(higher dividend yield)
QualityPFE(higher ROIC)
Valuation
| Metric | ABT | PFE |
|---|---|---|
| P/E ratio | 24.56 | 20.01● |
| Forward P/E | 14.56 | 9.25● |
| P/S ratio | 3.41 | 2.37● |
| P/B ratio | 2.96 | 1.67● |
| PEG ratio | 2.99 | — |
| EV / EBITDA | 17.30 | 12.72● |
| FCF yield | 4.79% | 6.31%● |
Profitability
| Metric | ABT | PFE |
|---|---|---|
| Gross margin | 56.38% | 69.35%● |
| Operating margin | 18.17% | 23.45%● |
| Net margin | 13.91%● | 11.83% |
| ROE | 12.06%● | 8.31% |
| ROIC | 8.43% | 8.84%● |
Dividends
| Metric | ABT | PFE |
|---|---|---|
| Dividend yield | 2.77% | 6.56%● |
| Payout ratio | 65.24% | 126.47% |
Growth (annualized)
| Metric | ABT | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 3.87% | 8.22%● |
| EPS CAGR (5Y) | 8.22%● | -3.78% |
| FCF CAGR (5Y) | -0.61%● | -3.79% |
| Total return CAGR (5Y) | -2.49%● | -3.33% |
Frequently asked
- Which is better, ABT or PFE?
- It depends on your goal. value: PFE (lower P/E); growth: PFE (faster 5Y revenue CAGR); income: PFE (higher dividend yield); quality: PFE (higher ROIC). Across all compared metrics, PFE leads 11 to 5.
- Is ABT or PFE cheaper?
- On trailing earnings, PFE is cheaper: ABT trades at a 24.56 P/E and PFE at 20.01.
- Which has grown faster, ABT or PFE?
- Over the past five years, PFE grew revenue faster — ABT at a 3.87% CAGR versus PFE at 8.22%.
- Does ABT or PFE pay a bigger dividend?
- ABT yields 2.77% and PFE yields 6.56% based on trailing dividends and the latest price.
- Is ABT or PFE more profitable?
- ABT runs the higher net margin — ABT at 13.91% versus PFE at 11.83%.
- Which has been the better investment, ABT or PFE?
- Over the past 10-year, ABT delivered the higher annualized total return — ABT at 10.72% versus PFE at 2.13%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioPfizer P/E ratioAbbott Laboratories dividend yieldPfizer dividend yieldAbbott Laboratories ROEPfizer ROEAbbott Laboratories operating marginPfizer operating marginAbbott Laboratories revenue growthPfizer revenue growthAbbott Laboratories free cash flowPfizer free cash flow
Abbott Laboratories & Pfizer appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.